FDG-PET Imaging in Cervical Cancer

被引：29
|
作者：
Gandy, Nemi [1 ]
Arshad, Mubarik A. [1 ]
Park, Won-Ho E. [2 ]
Rockall, Andrea G. [2 ,3 ]
Barwick, Tara D. [1 ,3 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Dept Imaging, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Clin Oncol, London, England
[3] Hammersmith Hosp, Imperial Coll London Canc Imaging Ctr, Dept Surg & Canc, London, England
来源：
SEMINARS IN NUCLEAR MEDICINE | 2019年 / 49卷 / 06期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; INTRATUMORAL METABOLIC HETEROGENEITY; STANDARDIZED UPTAKE VALUE; LYMPH-NODE METASTASIS; PROGNOSTIC VALUE; F-18-FDG PET; TREATMENT RESPONSE; RADIATION-THERAPY; TEXTURAL FEATURES; DIAGNOSTIC-VALUE;
D O I：
10.1053/j.semnuclmed.2019.06.007
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
FDG-PET/CT has an established role in the initial staging of locally advanced cervical cancers, particularly in evaluation of nodal disease and distant metastases. It is common practice to perform FDG-PET/CT 3 months postcompletion of chemoradiotherapy as it can predict outcome and be used to tailor management, including adjuvant therapy and follow-up. It is also routinely used prior to pelvic exenterative surgery to ensure there is no disease outside the pelvis. There is growing evidence that FDG-PET-derived parameters are prognostic and could potentially be used to tailor therapy. This review outlines the use of FDG-PET/CT imaging in cervical cancer. Crown Copyright (C) 2019 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：461 / 470
页数：10
相关论文
共 50 条
  • [1] FDG-PET in the evaluation of cervical cancer
    Macapinlac, HA
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : S171 - S172
  • [2] Imaging Uterine Cervical Cancer with FDG-PET/CT: Direct Comparison with PET
    Tatsumi, Mitsuaki
    Cohade, Christian
    Bristow, Robert E.
    Wahl, Richard L.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (04) : 229 - 235
  • [3] Imaging Uterine Cervical Cancer with FDG-PET/CT: Direct Comparison with PET
    Mitsuaki Tatsumi
    Christian Cohade
    Robert E. Bristow
    Richard L. Wahl
    [J]. Molecular Imaging and Biology, 2009, 11 : 229 - 235
  • [4] FDG-PET imaging in duodenal cancer
    Naoto Watanabe
    Shinichi Hayashi
    Hiroshi Kato
    Masashi Shimizu
    Yuichi Kamisaki
    Kyo Noguchi
    Mika Kishida
    Ichiro Matsunari
    Kinichi Hisada
    Hikaru Seto
    [J]. Annals of Nuclear Medicine, 2004, 18 : 351 - 353
  • [5] FDG-PET imaging in duodenal cancer
    Watanabe, N
    Hayashi, S
    Kato, H
    Shimizu, M
    Kamisaki, Y
    Noguchi, K
    Kishida, M
    Matsunari, I
    Hisada, K
    Seto, H
    [J]. ANNALS OF NUCLEAR MEDICINE, 2004, 18 (04) : 351 - 353
  • [6] Staging of Cervical Cancer Patients with FDG-PET
    Mukhortova, O.
    Aslanidis, I.
    Shurupova, I.
    Kaeva, I.
    Ashrafjan, L.
    Alimardonov, D.
    Shavladze, Z.
    Konov, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S427 - S427
  • [7] FDG-PET for management of cervical and ovarian cancer
    Havrilesky, LJ
    Kulasingam, SL
    Matchar, DB
    Myers, ER
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 183 - 191
  • [8] Posttherapy surveillance monitoring of cervical cancer by FDG-pet
    Grigsby, PW
    Siegel, BA
    Dehdashti, F
    Mutch, DG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (04): : 907 - 913
  • [9] Evaluation of FDG-PET in patients with cervical cancer.
    Sugawara, Y
    Eisbruch, A
    Recker, B
    Kison, PV
    Wahl, RL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05): : 66P - 66P
  • [10] FDG-PET GUIDED IMRT FOR PATIENTS WITH CERVICAL CANCER
    Grigsby, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S10 - S10
12345